My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
Login
Register
money
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Menu
Research
My Stocks
Tools
Recent
Markets
Price Target
Rocket Refocuses Pipeline As Gene Therapy Sentiment Sours
Rocket Pharmaceuticals downgraded by BofA after FDA halts Danon disease trial; company pivots toward earlier-stage gene therapy programs.
Investor Reaction To Predictable Mobileye Earnings Was Negative: Analyst
Analyst reiterates buy rating on Mobileye (MBLY) with $18 price target. Stock traded lower due to conservative Q4 outlook, but Q3 guidance beat consensus.
Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance
Edwards Lifesciences beat Q2 estimates and raised its 2025 sales outlook as TAVR and TMTT segments drove double-digit revenue growth.
Google Cloud, YouTube, And Search Drive Big Upside: Goldman Sachs
Alphabet Q2 results addressed investor concerns around rising capital expenditures and long-term competitiveness in AI.
Southwest's Rocky Q3 Outlook Sparks Doubts Over Steep Q4 Profit Climb
Southwest's weak Q3 outlook and steep Q4 revenue targets raise concerns over its ability to meet full-year profitability goals.
Coursera's Upbeat Outlook Drives Stock Higher
Coursera shares soar over 32% as strong Q2 results and rising consumer momentum boost long-term growth expectations.
Union Pacific's Turnaround Gains Momentum With Stellar Q2 Operations
Union Pacific Corp. (NYSE: UNP) is showing strong growth in operations and finances, supported by productivity gains and a earnings beat. Analysts raise price forecast and see potential for merger with Norfolk Southern.
Gilead's Newly Approved HIV Prevention Drug Poised To Add Billions To Future Sales
Gilead upgraded to Buy by Needham as Yeztugo gains physician favor, with sales forecast to reach $6.4 billion by 2035, exceeding prior estimates.
Why Palantir Is The 'AI All-Star' You Need To Watch
Palantir gains spotlight as it eyes a $24B revenue future, fueled by AI momentum, margin strength, and rising defense tech prominence.
These Analysts Boost Their Forecasts On TechnipFMC Following Upbeat Q2 Earnings
Edwards Lifesciences Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Results
These Analysts Boost Their Forecasts On Labcorp Following Better-Than-Expected Q2 Earnings
Dow Analysts Slash Their Forecasts After Weak Q2 Results
Imax Analysts Increase Their Forecasts After Q2 Results
These Analysts Raise Their Forecasts On Blackstone Following Q2 Earnings
Coursera Analysts Boost Their Forecasts After Upbeat Q2 Results
Nasdaq To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Friday
Wall Street's Most Accurate Analysts Weigh In On 3 Real Estate Stocks With Over 6% Dividend Yields
Charter Communications Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Booz Allen Hamilton Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Top Wall Street Forecasters Revamp HCA Healthcare Expectations Ahead Of Q2 Earnings
Centene Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Nike And Jordan Power Academy Sports' Store Upgrade
Academy Sports & Outdoors shares dip 2.8% as the company leans on enhanced merchandising, RFID rollout and operational upgrades to stabilize performance.
Freeport-McMoRan Eyes Major Gains From US Copper Tariff
Freeport-McMoRan Inc. reported strong Q2 results, sparking positive outlook from analysts like RBC's Sam Crittenden who reaffirmed a $54 price forecast.
Pegasystems Affirms Outlook As Cloud Strategy Powers Momentum
Pegasystems exceeded expectations in Q2 2025, with robust revenue and cloud growth. Analysts maintain a bullish outlook, raising price forecast.
Buy IBM Stock On 'Short-Term Weakness,' Analyst Asserts After Q2 Performance
Wedbush analyst maintains Outperform rating and $325 price forecast for IBM. Strong fiscal Q2 results and reaffirmed full-year guidance. AI book of business accelerates to $7.5 billion.
These Analysts Revise Their Forecasts On Northern Trust Following Q2 Earnings
Verizon And Federal Wins Power Ribbon Communications' Confident Outlook
Ribbon Communications (NASDAQ: RBBN) had a strong second quarter in 2025, with $221 million in revenue, driven by demand and customer wins. Gross margins slightly pressured but full-year outlook remains positive.
These Analysts Cut Their Forecasts On SEI Investments After Q2 Results
Tesla Stock Faces 'Critical Milestone' Ahead: Here's What Analysts Are Flagging As Next Key Catalyst
What's the next key moment for Tesla? Analysts highlight this item as the key from Q2 results and for the future of the company.